Literature DB >> 19158053

Distal renal tubular acidosis due to primary hyperparathyroidism.

Jayaraman Muthukrishnan1, K V S Hari Kumar, Ratan Jha, Sangeeta Jha, Kirtikumar D Modi.   

Abstract

OBJECTIVE: To present 4 cases of distal renal tubular acidosis (RTA) in patients with primary hyperparathyroidism (PHPT) and discuss their possible etiopathogenetic correlation.
METHODS: We diagnosed distal RTA in 4 patients with symptomatic primary PHPT on the basis of the baseline biochemical variables and the results of the ammonium chloride loading test. Complete resolution of distal RTA was documented after surgical cure of PHPT by removal of a parathyroid adenoma.
RESULTS: All our patients presented with symptomatic bone disease and metabolic myopathy. One patient presented with recurrent renal stones. Inappropriately alkaline fasting urine (pH >5.5) in association with a normal anion gap metabolic acidosis suggested the diagnosis of distal RTA. All cases were confirmed by an ammonium chloride loading test. Three patients responded to surgical cure of PHPT by normalization of the acid-base status.
CONCLUSION: Hypercalciuria in PHPT can lead to nephrocalcinosis and renal tubular dysfunction, which manifests as distal RTA. Cure of distal RTA after surgical treatment of PHPT establishes PHPT as the primary cause of distal RTA in these cases.

Entities:  

Mesh:

Year:  2008        PMID: 19158053     DOI: 10.4158/EP.14.9.1133

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  9 in total

1.  Distal renal tubular acidosis in primary hyperparathyroidism.

Authors:  Tom Edward Ngo Lo; Iris Thiele Isip Tan
Journal:  BMJ Case Rep       Date:  2015-01-29

2.  Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden.

Authors:  Helene Siilin; Ewa Lundgren; Hans Mallmin; Dan Mellström; Claes Ohlsson; Magnus Karlsson; Eric Orwoll; Osten Ljunggren
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

Review 3.  Current opinions on nephrolithiasis associated with primary hyperparathyroidism.

Authors:  Xiaoming Cong; Luming Shen; Xiaojian Gu
Journal:  Urolithiasis       Date:  2018-01-19       Impact factor: 3.436

4.  Renal manifestations of primary hyperparathyroidism.

Authors:  Anurag Ranjan Lila; Vijaya Sarathi; Varsha Jagtap; Tushar Bandgar; Padma S Menon; Nalini Samir Shah
Journal:  Indian J Endocrinol Metab       Date:  2012-03

5.  Surgery or no surgery: What works best for the kidneys in primary hyperparathyroidism? A study in a multi-ethnic Asian population.

Authors:  Yu Kwang Donovan Tay; Joan Khoo; Manju Chandran
Journal:  Indian J Endocrinol Metab       Date:  2016 Jan-Feb

6.  Primary hyperparathyroidism: A changing scenario in India.

Authors:  Sangeeta Jha; Muthukrishnan Jayaraman; Aman Jha; Ratan Jha; Kirtikumar D Modi; Jayant V Kelwadee
Journal:  Indian J Endocrinol Metab       Date:  2016 Jan-Feb

Review 7.  Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.

Authors:  A A Khan; D A Hanley; R Rizzoli; J Bollerslev; J E M Young; L Rejnmark; R Thakker; P D'Amour; T Paul; S Van Uum; M Zakaria Shrayyef; D Goltzman; S Kaiser; N E Cusano; R Bouillon; L Mosekilde; A W Kung; S D Rao; S K Bhadada; B L Clarke; J Liu; Q Duh; E Michael Lewiecki; F Bandeira; R Eastell; C Marcocci; S J Silverberg; R Udelsman; K Shawn Davison; J T Potts; M L Brandi; J P Bilezikian
Journal:  Osteoporos Int       Date:  2016-09-09       Impact factor: 4.507

8.  Evaluating distal renal tubular acidification function in primary hyperparathyroidism and its effects on bone mineral density.

Authors:  Wangna Tang; Hongwei Jia; Baoping Wang; Yun Chai; Tong Liu; Hao Wang; Chenlin Dai
Journal:  BMC Musculoskelet Disord       Date:  2021-01-12       Impact factor: 2.362

9.  Rickets with hypophosphatemia, hypokalemia and normal anion gap metabolic acidosis: not always an easy diagnosis.

Authors:  Saurav Shishir Agrawal; Chandan Kumar Mishra; Chhavi Agrawal; Partha Pratim Chakraborty
Journal:  BMJ Case Rep       Date:  2020-01-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.